NCT05054829 Establishment of Social Skills Training Group in Adults With Autism Spectrum Disorder and Effectiveness Analysis
| NCT ID | NCT05054829 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Social Skill Training Group |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2017-03-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2017-03-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to examine the effectiveness of social skill training group in adults with autism spectrum disorders.
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 45 years * having relational problems * having motivation to participate * good chinese speaking * having a healthy cargiver join together * IQ \> 70 (WAIS) * Autism Spectrum Quotient \> 26 Exclusion Criteria: * ever had psychosis and neurological diseases * visual and hiring impairment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05054829 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Social Skill Training Group. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05054829 currently recruiting?
Yes, NCT05054829 is actively recruiting participants. Contact the research team at chienyiling@gmail.com for enrollment information.
Where is the NCT05054829 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT05054829 clinical trial?
NCT05054829 is sponsored by National Taiwan University Hospital. The trial plans to enroll 160 participants.